(Q57413008)

English

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes

scientific article published on 01 July 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

type-1 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin detemir

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Kølendorf K

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Ross GP

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Pavlic-Renar I

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Perriello G

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Philotheou A

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Gall MA

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 July 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

729-735

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01862.X

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01862.X

21 January 2018

Insulins today and beyond

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01862.X

21 January 2018

New insulins in the treatment of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01862.X

21 January 2018

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01862.X

21 January 2018

Reducing hypoglycaemia with insulin analogues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01862.X

21 January 2018

Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01862.X

21 January 2018

The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01862.X

21 January 2018

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01862.X

21 January 2018

Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01862.X

21 January 2018

Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01862.X

21 January 2018

Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01862.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2006.01862.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16842476%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57413008&oldid=2032324914"